Searchable abstracts of presentations at key conferences in endocrinology

ea0031p322 | Steroids | SFEBES2013

Steroid profile response to angiotensin II and ACTH in normal volunteer under high and low salt conditions

McManus Frances

Introduction: Steroid profiling using liquid chromatography with tandem mass spectroscopy (LC:MS) has a low cost per sample and has the potential for high through-put processing. However, although this technology is becoming more widely used, little is known of the normal ranges of many less well studied steroid compounds as well as their response to a variety of physiological stimulants.Methods: Volunteers were recruited to a randomised, double blind cr...

ea00100wf2.1 | Workshop F: Disorders of the parathyroid glands, calcium metabolism and bone | SFEEU2024

Five pints of milk a day keeps the hypocalcaemia at bay: autosomal dominant hypocalcaemia

Lawless Thomas , McManus Frances

An 18-year-old male, presenting with unexplained weight loss, was found to have asymptomatic hypocalcaemia (adjusted 1.72 mmol/l, range 2.2-2.6 mmol/l) and hyperphosphataemia (2.05 mmol/l, range 0.8-1.5 mmol/l). He had a background of repaired perimembranous VSD, mild learning difficulties and developmental delay. Parathyroid hormone (PTH) was found to be undetectable and 25-OH Vitamin D insufficient (43 nmol/l). Urine calcium/creatinine ratio was elevated (0.81 mmol/mmol). Th...

ea0034p184 | Neoplasia, cancer and late effects | SFEBES2014

Diagnosis of adrenocortical carcinoma; urinary steroid profiles measured by GC:MS

McManus Frances , Hannay Jonathan , O'Dwyer Patrick , Shapiro David , Freel Marie

Introduction: Gas chromatography/mass spectrometry based steroid profiling has been proposed as a tool for differentiating adrenocortical carcinoma (ACC) from benign adrenocortical adenoma (ACA). We retrospectively examined urinary steroid profiles from ten patients with ACC and 14 patients with ACA to determine, if the steroid profiles were predictive in distinguishing benign from malignant disease.Methods: Patients who had undergone adrenalectomy for r...

ea0034p352 | Steroids | SFEBES2014

Urinary steroid profiling by Gas-Chromatography Mass-Spectrometry (GC–MS) is not helpful in the diagnosis of Cushing's Syndrome

Johns Emma , Shapiro David , McManus Frances , Freel Marie

Introduction: The diagnosis of Cushing’s syndrome (CS) can be challenging and there is no single gold standard diagnostic test. Endocrinologists rely on a combination of plasma cortisol (before and after dexamethasone), midnight salivary cortisol and urinary free cortisol (UFC) to make the diagnosis. Assessment of urinary corticosteroids and their metabolites, measured by gas chromatography–mass spectrometry (GC–MS), provide a comprehensive picture of corticoste...

ea0028p329 | Steroids | SFEBES2012

Risk of iatrogenic Cushings syndrome and adrenal suppression in antiretroviral regimes including CYP450 3A4 inhibitors

McManus Frances , White Bethanna , MacConnachie Alisdair , Perry Colin

A 60 year old female from Zimbabwe with an eight year history of HIV infection presented with malaise and facial swelling. She had been established on antiretroviral treatment (Kivexa (lamivudine / abacavir) and Kaletra (lopinivir / ritonavir)) since shortly after her initial diagnosis. One month earlier she had received an injection of intramuscular triamcinolone acetate to treat an inflammatory polyarthropathy. She was also prescribed inhaled salmeterol xinafoate 50 mcg/flut...

ea0025oc2.3 | Steroids | SFEBES2011

APEX1, a novel, negative regulator of aldosterone synthase activity, differentially binds to a single nucleotide polymorphism in the aldosterone synthase gene and represses transcriptional activity both in vitro and in vivo

McManus Frances , Sands William , Fraser Robert , Davies Eleanor , Connell John

Aldosterone synthesis is heritable; a single nucleotide polymorphism (SNP) in the promoter of the aldosterone synthase gene (position −344, rs1799998) has been associated with an increased plasma aldosterone levels and hypertension. However, deletion of this site has no effect on gene transcription in vitro and therefore the mechanism that links genotype with phenotype is unclear.We identified a polymorphism at position −1651 T/C (rs13...

ea0021p359 | Steroids | SFEBES2009

Variation in the aldosterone synthase gene may alter gene transcription via altered transcription factor binding

McManus Frances , Sands William , Davies Eleanor , Connell John

The aldosterone synthase gene encodes the final step in the production of aldosterone. The aldoststerone synthase gene is polymorphic and variants within the gene and the regulatory region have been associated with hypertension and a phenotype of relatively higher level of aldosterone and its metabolites. However to date; none of the polymorphisms in the regulatory region of CYP11B2 have been shown to alter transcription. Seven novel polymorphisms in the promoter region of CYP...

ea0050ep077 | Neuroendocrinology and Pituitary | SFEBES2017

AIP mutation causing familial pituitary tumours

Cordiner Ruth , McManus Frances , Hughes Kate , Panarelli Maurizio , Boyle James , Drummond Russell , Carty David

Familial isolated pituitary adenoma (FIPA) is an increasingly recognised cause of familial pituitary tumours with autosomal dominant inheritance. An increased population risk of AIP mutations has recently been reported in Ireland. We present the cases of three siblings, with likely AIP related disease, attending endocrinology clinics in Glasgow. Patient one has been confirmed to be an AIP mutation carrier.Patient 1 ...

ea0050ep077 | Neuroendocrinology and Pituitary | SFEBES2017

AIP mutation causing familial pituitary tumours

Cordiner Ruth , McManus Frances , Hughes Kate , Panarelli Maurizio , Boyle James , Drummond Russell , Carty David

Familial isolated pituitary adenoma (FIPA) is an increasingly recognised cause of familial pituitary tumours with autosomal dominant inheritance. An increased population risk of AIP mutations has recently been reported in Ireland. We present the cases of three siblings, with likely AIP related disease, attending endocrinology clinics in Glasgow. Patient one has been confirmed to be an AIP mutation carrier.Patient 1 ...

ea0031p171 | Neoplasia, cancer and late effects | SFEBES2013

Recurrent bronchial carcinoid tumour presenting as a thyroid nodule

Hall Lesley , Smith Chris , Carty David , McManus Frances , Reed Nick , Freel Marie , Perry Colin

A 38-year-old lady presented in 2003 with a 2 years history of recurrent pneumonia, with CXR having demonstrated intermittent right lower zone consolidation. CT of chest revealed dense right lower lobe consolidation and a 2.5 cm tumour occluding the right lower lobe orifice was found on bronchoscopy. Strongly positive immunohistochemical staining for chromogranin, NCAM, PGP 9.5 and synaptophysin suggested carcinoid so right lower and middle lobectomy was performed. Histology c...